Crystal structure of hiv protease complexed with methyl n-[(1s)-1-[[2-[(3s)-3-[(4-aminophenyl)methylamino]-4-hydroxy-butyl]phenyl]carbamoyl]-2,2-diphenyl-ethyl]carbamate Deposition Author(s): Su, H.P.
Date: 2016-03-21 Method: X-RAY DIFFRACTION Resolution: 1.5 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 5IVR_A , 5IVR_B
Crystal structure of hiv protease complexed with methyl n-[(1s)-1-benzhydryl-2-[2-[2-[(2r,5s)-5-(benzylcarbamoyloxymethyl)morpholin-2-yl]ethyl]anilino]-2-oxo-ethyl]carbamate Deposition Author(s): Su, H.P.
Date: 2016-03-21 Method: X-RAY DIFFRACTION Resolution: 1.46 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 5IVS_A , 5IVS_B
Crystal structure of hiv protease complexed with [(1s)-1-[(s)-(4-chlorophenyl)-(3,5-difluorophenyl)methyl]-2-[[5-fluoro-4-[2-[(2r,5s)-5-(2,2,2-trifluoroethylcarbamoyloxymethyl)morpholin-4-ium-2-yl]ethyl]pyridin-1-ium-3-yl]amino]-2-oxo-ethyl]ammonium Deposition Author(s): Su, H.P.
Date: 2016-03-21 Method: X-RAY DIFFRACTION Resolution: 1.15 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 5IVT_A , 5IVT_B
Ground state sampled during rdc restrained replica-averaged metadynamics (ram) simulations of the hiv-1 tar complexed with cyclic peptide mimetic of tat Deposition Author(s): Bardaro Jr., M.F. , Borkar, A.N. , Varani, G. , Vendruscolo, M.
Date: 2016-03-28 Method: SOLUTION NMR Resolution: N.A. Organism(s): Human Immunodeficiency Virus 1 , Synthetic Construct Sequences Data: 5J0M_A , 5J0M_B
Excited state (bound-like) sampled during rdc restrained replica-averaged metadynamics (ram) simulations of the hiv-1 tar complexed with cyclic peptide mimetic of tat Deposition Author(s): Bardaro, M.F. , Borkar, A.N. , Varani, G. , Vendruscolo, M.
Date: 2016-03-29 Method: SOLUTION NMR Resolution: N.A. Organism(s): Human Immunodeficiency Virus 1 , Synthetic Construct Sequences Data: 5J1O_A , 5J1O_B
Intermediate state lying on the pathway of release of tat from hiv-1 tar. Deposition Author(s): Bardaro Jr., M.F. , Borkar, A.N. , Varani, G. , Vendruscolo, M.
Date: 2016-03-30 Method: SOLUTION NMR Resolution: N.A. Organism(s): Human Immunodeficiency Virus 1 , Synthetic Construct Sequences Data: 5J2W_A , 5J2W_B
Hiv-1 wild type protease with grl-097-13a (a adamantane p1-ligand with bis-thf in p2 and isobutylamine in p1') Deposition Author(s): Agniswamy, J. , Wang, Y.-F. , Weber, I.T.
Date: 2016-04-19 Method: X-RAY DIFFRACTION Resolution: 1.49 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 5JFP_A , 5JFP_B
Hiv-1 wild type protease with grl-007-14a (a adamantane p1-ligand with bis-thf in p2 and benzylamine in p1') Deposition Author(s): Agniswamy, J. , Wang, Y.-F. , Weber, I.T.
Date: 2016-04-19 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 5JFU_A , 5JFU_B
Hiv-1 wild type protease with grl-031-14a (a adamantane p1-ligand with tetrahydropyrano-tetrahydrofuran in p2 and isobutylamine in p1') Deposition Author(s): Agniswamy, J. , Wang, Y.-F. , Weber, I.T.
Date: 2016-04-19 Method: X-RAY DIFFRACTION Resolution: 1.16 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 5JG1_A , 5JG1_B
Inhibitor resistant mutant catalytic core domain of hiv-1 integrase Deposition Author(s): Feng, L. , Kobe, M. , Kvaratskhelia, M.
Date: 2016-04-26 Method: X-RAY DIFFRACTION Resolution: 1.758 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 5JL4_A , 5JL4_B